financetom
Business
financetom
/
Business
/
Balchem's Q3 Adjusted Earnings, Net Sales Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Balchem's Q3 Adjusted Earnings, Net Sales Rise
Nov 3, 2024 11:29 AM

07:18 AM EDT, 10/25/2024 (MT Newswires) -- Balchem ( BCPC ) reported Q3 adjusted net earnings Friday of $1.13 per diluted share, up from $1.04 a year earlier.

Two analysts polled by Capital IQ expected $1.12.

Net sales for the quarter ended Sept. 30 were $239.9 million, compared with $229.9 million a year earlier.

Three analysts surveyed by Capital IQ expected $241.9 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Niagen Bioscience Raises Fiscal 2025 Net Sales Growth Outlook; Shares Up Pre-Bell
Niagen Bioscience Raises Fiscal 2025 Net Sales Growth Outlook; Shares Up Pre-Bell
Oct 6, 2025
09:11 AM EDT, 10/06/2025 (MT Newswires) -- Niagen Bioscience ( NAGE ) said Monday that it now expects fiscal 2025 net sales to increase by 25% to 30% from a year earlier, up from a prior outlook of 22% to 27% growth. Four analysts polled by FactSet expect net sales of $125.7 million. Shares of the company were up 7.5%...
Kratos Awarded Phase 1 Organic Sustainment Contract for US Navy's AN/SPY-1 Radar Systems
Kratos Awarded Phase 1 Organic Sustainment Contract for US Navy's AN/SPY-1 Radar Systems
Oct 6, 2025
09:09 AM EDT, 10/06/2025 (MT Newswires) -- Kratos Defense & Security Solutions (KTOS) said Monday that it has been awarded a phase 1 contract to develop an organic sustainment capability for the US Navy's AN/SPY-1 radar systems. The single-award agreement has an initial total projected ceiling of $175 million across multiple phases, the company said. The contract will be executed...
Phathom Pharmaceuticals Names Sanjeev Narula Finance, Business Chief
Phathom Pharmaceuticals Names Sanjeev Narula Finance, Business Chief
Oct 6, 2025
09:12 AM EDT, 10/06/2025 (MT Newswires) -- Phathom Pharmaceuticals ( PHAT ) said Monday it has named Sanjeev Narula its chief financial and business officer. Narula was previously Intra-Cellular Therapies' CFO, the company said. Phathom Pharmaceuticals' ( PHAT ) shares were up nearly 2% in recent Monday premarket activity. ...
Fifth Third Bancorp to Acquire Comerica in $10.9 Billion All-Stock Deal
Fifth Third Bancorp to Acquire Comerica in $10.9 Billion All-Stock Deal
Oct 6, 2025
09:09 AM EDT, 10/06/2025 (MT Newswires) -- Fifth Third Bancorp ( FITB ) on Monday agreed to acquire regional lender Comerica ( CMA ) in an all-stock deal worth $10.9 billion to create one of the largest banks in the US with roughly $288 billion in assets. Under the terms, Comerica's ( CMA ) shareholders will receive 1.8663 Fifth Third...
Copyright 2023-2026 - www.financetom.com All Rights Reserved